The price reductions apply with immediate effect and have been made to a key collection of over 10 products which have been specifically identified as those that are most in demand, appearing on customer quote requests most frequently. They include amino and thiol linkers, biotin and 6-FAM labels, and PNA monomers among others.
Dr John Bremner, CEO at Link Technologies, explained: “Quality will always come first for our customers and remains our priority. However, we are challenging the perception that this only comes at a high cost. As a primary manufacturer of many of the most common products used in the industry we are ideally positioned to provide both high quality and highly competitive prices.”
Link Technologies provides a broad range of reagents for DNA, RNA and PNA synthesis and this step is the first of several upcoming developments to further benefit customers involved in oligo synthesis.
For further detail on the recent price changes, please click here (http://www.linktech.co.uk/